Our study revealed loss of CHRM1 protein in the temporal cortices of a subset of AD patients that was significantly associated with poor survival, i.e., early death occurred <65-75 years (Sabbir et al., 2022). The gene discussed is CHRM1; the disease is Alzheimer disease.